Suchergebnisse - "Georgiev, George I"

PubPharm (9)

1

A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice

enthalten in: PLoS pathogens | 2022

von Malonis, R. | Georgiev, G. | Haslwanter, D. | +9

2

Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo

enthalten in: Cell chemical biology | 2022

von Georgiev, G. | Malonis, R. | Wirchnianski, A. | +10

3

Longitudinally monitored immune biomarkers predict the timing of COVID-19 outcomes

enthalten in: PLoS computational biology | 2022

von Lasso, G. | Khan, S. | Allen, S. | +29

4

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants

enthalten in: mBio | 2021

von Haslwanter, D. | Dieterle, M. | Wec, A. | +27

5

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative Immunoglobulin G Assays : The Value of Numeric Reporting

enthalten in: Archives of pathology & laboratory medicine | 2021

von Forest, S. | Orner, E. | Goldstein, D. | +17

6

Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts

enthalten in: mSphere | 2021

von Bortz, R. | Florez, C. | Laudermilch, E. | +38

UpdateOf: medRxiv. 2020 Sep 11;:. - PMID 32935116

7

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

enthalten in: JCI insight | 2021

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

UpdateOf: medRxiv. 2020 Dec 04;:. - PMID 33300012

8

Characterization of the SARS-CoV-2 S Protein : Biophysical, Biochemical, Structural, and Antigenic Analysis

enthalten in: ACS omega | 2021

von Herrera, N. | Morano, N. | Celikgil, A. | +31

UpdateOf: bioRxiv. 2020 Jun 17;:. - PMID 32587972

9

A Comparison of Iron Oxide Particles and Silica Particles for Tracking Organ Recellularization

enthalten in: Molecular imaging | 2018

von Kobes, J. | Georgiev, G. | Louis, A. | +6

1
[1]